VitaDAO is a new type of entity in the biotech research space, and its members will own the intellectual property assets that result from the projects it supports and funds.
Its mission is to extend the human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.
Our increased understanding of the underlying cause of all major age-related diseases is driving progress in the development of new therapies to prevent or reverse age-related diseases like cancer or Alzheimer's.
The VitaDAO strategy VitaDAO is building a global community of longevity scientists and enthusiasts discovering and funding the most promising research.
We are financing, researching and collectively supporting promising areas of longevity research targeting the root causes of age-related diseases to increase human health and quality of life.
We are funding early stage research, and try to turn it into biotech companies.
We build a global community of longevity scientists and enthusiasts in research.
We believe in an open and democratic manner in funding projects that help to extend the human lifespan by researching, financing, and commercializing longevity therapeutics .
We fund early stage research with micro-grants that might create intellectual property or with a longevity startup and try to turn it into biotech companies.
We believe in awarding (The Longevity Prize) outstanding progress in longevity research — crowdsourced and curated by leading industry experts.